PerkinElmer agrees to acquire antibody maker BioLegend for $5.25bn
On acquisition, BioLegend’s campus in San Diego will be turned into PerkinElmer’s CoE to develop reagent content.
deal
HeartFlow to go public with $2.8bn SPAC merger deal
The merged company will operate as HeartFlow Group and focus on transforming the precision heart...
Surmodics acquires Vetex Medical to boost thrombectomy portfolio
According to the agreement, Surmodics made an upfront payment of $39.9m to Vetex.
Dante Labs acquires CCG.ai to build precision oncology software
The integrated platform would combine medical, germline, somatic and liquid biopsy data analysis for targeted...
How is activity in the medical sector recovering from Covid-19’s impact?
Analysis of jobs, deals, stock prices and financial filings and news sentiments now show medical...
Komodo Health secures $220m in Series E funding round
Health analytics start-up Komodo Health has closed a $220m Series E funding round, giving the company a valuation of $3.3bn.
Roche to acquire GenMark Diagnostics for $1.8bn
Roche has signed a definitive merger agreement to completely acquire GenMark Diagnostics for a total transaction value of nearly $1.8bn.
Boston Scientific to buy cardiac monitor provider Preventice Solutions
Boston Scientific has signed a definitive agreement to acquire US-based cardiac monitors provider Preventice Solutions to expand its rhythm management diagnostics portfolio and capabilities.
Optum to acquire health technology company Change Healthcare
UnitedHealth Group's Optum is set to acquire Change Healthcare for $25.75 per share in cash for the latter’s common stock.
Olympus to acquire Veran Medical Technologies for $340m
Olympus has signed an agreement to acquire medical device maker Veran Medical Technologies (VMT) through its subsidiary Olympus Corporation of the Americas (OCA) in a deal worth up to $340m.
Gyrus Capital signs deal to acquire LivaNova heart valve business
Investment firm Gyrus Capital has signed an agreement to acquire the LivaNova heart valve (HV) business, through entities funded and controlled by the company.
